Clinigen Group PLC Company Profile (LON:CLIN)

About Clinigen Group PLC

Clinigen Group PLC logoClinigen Group plc is a United Kingdom-based global pharmaceutical and services company. The Company consists of four businesses that provide medicines to patients with unmet needs, through clinical trials, licensed and unlicensed supply. It operates through four segments: Clinigen Clinical Trial Services (CTS), Idis Managed Access (MA), Idis Global Access (GA) and Clinigen Specialty Pharmaceuticals (SP). The CTS segment sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies. The MA segment specializes in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies. The GA segment provides ethical access to post approval and short-supply medicines, in regions where patients have low or non-existent access to these often-essential drugs. The SP segment manufactures and distributes its own and in-license specialist, hospital-only medicines.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: CLIN
  • CUSIP:
Key Metrics:
  • Previous Close: $9.36
  • 50 Day Moving Average: $655.62
  • 200 Day Moving Average: $599.30
  • 52-Week Range: GBX 492.75 - GBX 739.50
  • Trailing P/E Ratio: 60.76
  • P/E Growth: 0.00
  • Market Cap: $821.67M
  • Outstanding Shares: 111,599,000
Additional Links:

Analyst Ratings

Consensus Ratings for Clinigen Group PLC (LON:CLIN) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 856.60

Analysts' Ratings History for Clinigen Group PLC (LON:CLIN)
Show:
DateFirmActionRatingPrice TargetDetails
9/28/2016Stifel NicolausReiterated RatingBuyGBX 800View Rating Details
9/28/2016Numis Securities LtdReiterated RatingBuyGBX 933View Rating Details
9/28/2016N+1 SingerReiterated RatingBuyGBX 800View Rating Details
9/28/2016Peel HuntReiterated RatingBuyGBX 1,000View Rating Details
1/20/2016Royal Bank Of CanadaLower Price TargetOutperformGBX 770 -> GBX 750View Rating Details
4/17/2015InvestecBoost Price TargetHoldGBX 546 -> GBX 550View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Clinigen Group PLC (LON:CLIN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Clinigen Group PLC (LON:CLIN)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Clinigen Group PLC (LON:CLIN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/28/2016GBX 2.700.38%11/3/201611/3/201611/25/2016
3/2/2016GBX 1.300.2%3/17/20163/17/20164/8/2016
9/22/2015GBX 2.300.32%10/15/201510/15/201511/6/2015
9/24/2014GBX 2.100.46%10/16/201410/16/201411/7/2014
2/26/2014GBX 10.19%3/5/20143/5/20143/28/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Clinigen Group PLC (LON:CLIN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2016Abell,MartinInsiderBuy11,296GBX 518£58,513.28
10/7/2015Edward Chilton,ShaunInsiderSell412,778GBX 685£2,827,529.30
6/3/2015John HartupInsiderSell23,934GBX 644£154,134.96
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Clinigen Group PLC (LON:CLIN)
DateHeadline
News IconClinigen Group PLC's (CLIN) "Buy" Rating Reaffirmed at Numis Securities Ltd (LON:CLIN)
myhealthbowl.com - September 30 at 4:40 PM
proactiveinvestors.co.uk logoClinigen's George passes on the baton (LON:CLIN)
www.proactiveinvestors.co.uk - September 30 at 4:40 PM
marketwatch.com logoClinigen full-year profit up 65%; CEO to step down (LON:CLIN)
www.marketwatch.com - September 29 at 9:11 AM
News IconInbev Nears SABMiller Merger; Clinigen, Smiths Group Net Jump (LON:CLIN)
www.123jump.com - September 29 at 9:11 AM
businesswire.com logoClinigen Group plc: Transformational Year Delivers 25% Growth in Adjusted EPS* (LON:CLIN)
www.businesswire.com - September 29 at 9:10 AM
publicnow.com logoShaun Chilton to take over as Chief Executive Officer (LON:CLIN)
www.publicnow.com - September 28 at 9:09 AM
publicnow.com logoFull year results for the 12 months ended 30 June 2016 (LON:CLIN)
www.publicnow.com - September 28 at 9:09 AM
publicnow.com logoClinigen Group - Full year results for the 12 months ended 30 June (LON:CLIN)
www.publicnow.com - September 28 at 9:09 AM
publicnow.com logoClinigen Group - Shaun Chilton to take over as Chief Executive Officer (LON:CLIN)
www.publicnow.com - September 28 at 9:09 AM
biz.yahoo.com logoFull Year 2016 Clinigen Group PLC Earnings Release - Before Market Open (LON:CLIN)
biz.yahoo.com - September 28 at 9:09 AM
4-traders.com logoClinigen : Notification of Capital Markets Day (LON:CLIN)
www.4-traders.com - September 27 at 8:50 AM
publicnow.com logoNotification of Capital Markets Day (LON:CLIN)
www.publicnow.com - September 27 at 8:50 AM
News IconCytoprotective Agent Ethyol Now Available (LON:CLIN)
www.empr.com - September 26 at 4:29 PM
streetinsider.com logoCumberland Pharma (CPIX) Announces Launch of Ethyol Promotion in U.S. (LON:CLIN)
www.streetinsider.com - September 26 at 4:29 PM
ft.com logoClinigen and Cumberland launch Ethyol in the US (LON:CLIN)
announce.ft.com - September 26 at 4:29 PM
investors.com logoClinigen/Cumberland launch oncology treatment in US (LON:CLIN)
www.proactiveinvestors.com - September 26 at 4:29 PM
finance.yahoo.com logoCumberland Pharmaceuticals Launches Promotion Of Ethyol® In The United States For Oncology Patient Support (LON:CLIN)
finance.yahoo.com - September 26 at 8:59 AM
morningstar.co.uk logoClinigen Says Cumberland Pharma Launches Ethyol For Injection In US (LON:CLIN)
www.morningstar.co.uk - September 26 at 8:59 AM
4-traders.com logoClinigen : and Cumberland Pharmaceuticals launch Ethyol® in the U.S. (LON:CLIN)
www.4-traders.com - September 26 at 8:59 AM
publicnow.com logoClinigen Group and Cumberland Pharmaceuticals launch Ethyol® in the U.S. (LON:CLIN)
www.publicnow.com - September 26 at 8:59 AM
capitalcube.com logoClinigen Group Plc breached its 50 day moving average in a Bearish Manner : CLIN-GB : September 14, 2016 (LON:CLIN)
www.capitalcube.com - September 14 at 8:30 AM
publicnow.com logoNotification of full year results date (LON:CLIN)
www.publicnow.com - September 7 at 8:29 AM
4-traders.com logoClinigen : Adoption of Financial Reporting Standard (FRS) 101 (LON:CLIN)
www.4-traders.com - August 31 at 9:02 AM
publicnow.com logoAdoption of Financial Reporting Standard (FRS) 101 (LON:CLIN)
www.publicnow.com - August 31 at 9:02 AM
finance.yahoo.com logoCumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol® (amifostine) For Oncology Patient Support (LON:CLIN)
finance.yahoo.com - August 23 at 4:24 PM
capitalcube.com logoETF’s with exposure to Clinigen Group Plc : August 18, 2016 (LON:CLIN)
www.capitalcube.com - August 18 at 9:32 PM
capitalcube.com logoClinigen Group Plc :CLIN-GB: Earnings Analysis: For the six months ended December 31, 2015 : August 17, 2016 (LON:CLIN)
www.capitalcube.com - August 17 at 11:16 AM
openpr.com logoIncreasing Prevalence in Emerging Economies to Benefit Demand for HPV, CMV Therapeutics, says TMR (LON:CLIN)
www.openpr.com - August 12 at 4:14 PM
openpr.com logoGlobal Human Papillomavirus (HPV) Therapeutics Market to Reach US$2.34 bn by 2020, Driven by Rising Prevalence of HPV Infections (LON:CLIN)
www.openpr.com - August 9 at 11:35 AM
proactiveinvestors.co.uk logoClinigen on track for £1bln market cap - CEO (LON:CLIN)
www.proactiveinvestors.co.uk - July 22 at 12:16 PM
breakingfinancenews.com logoClinigen Group (LON:CLIN) stock price target held steady at 1,000GBX as issued in a report today by Peel Hunt (LON:CLIN)
breakingfinancenews.com - July 21 at 9:46 PM
4-traders.com logoClinigen : Revenue And Profit Surge On Acquisitions, Organic Growth (LON:CLIN)
www.4-traders.com - July 20 at 5:21 PM
breakingfinancenews.com logoA statement released today by Numis about Clinigen Group(LON:CLIN) maintains the target price at 916GBX (LON:CLIN)
breakingfinancenews.com - July 20 at 5:21 PM
proactiveinvestors.co.uk logoClinigen Group well positioned after "transformational" year (LON:CLIN)
www.proactiveinvestors.co.uk - July 20 at 5:21 PM
morningstar.co.uk logoClinigen Group Issues 83,016 Shares In Option Exercise (ALLISS) (LON:CLIN)
www.morningstar.co.uk - July 8 at 9:19 PM
4-traders.com logoClinigen : Issues 83,016 Shares In Option Exercise (ALLISS) (LON:CLIN)
www.4-traders.com - July 7 at 11:49 AM
publicnow.com logoClinigen Group - Notice of Trading Update (LON:CLIN)
www.publicnow.com - July 1 at 3:41 AM
streetinsider.com logoHorizon Pharma (HZNP) Announces Submission of RAVICTI sNDA o Expand Age Range for Management of Urea Cycle Disorders (LON:CLIN)
www.streetinsider.com - June 30 at 4:30 PM
News IconHuman Papillomavirus and Cytomegalovirus Therapeutics Market Detailed Analysis and Forecast by 2020 (LON:CLIN)
empowerednews.net - June 30 at 4:30 PM
morningstar.co.uk logoClinigen's Idis Starts Managed Access Programme For Horizon's Ravicti (LON:CLIN)
www.morningstar.co.uk - June 29 at 12:22 PM
4-traders.com logoClinigen : and Horizon Pharma enter partnership to initiate European Managed Access program for RAVICTI® (glycerol phenylbutyrate) Oral Liquid (LON:CLIN)
www.4-traders.com - June 29 at 12:22 PM
proactiveinvestors.co.uk logoClinigen to manage access for Horizon drug (LON:CLIN)
www.proactiveinvestors.co.uk - June 29 at 12:22 PM
breakingfinancenews.com logoClinigen Group (LON:CLIN) target price maintained to GBX0 as announced today by Numis (LON:CLIN)
breakingfinancenews.com - June 24 at 4:22 PM
capitalcube.com logoClinigen Group Plc breached its 50 day moving average in a Bullish Manner : CLIN-GB : June 24, 2016 (LON:CLIN)
www.capitalcube.com - June 24 at 4:39 AM
News IconClinigen signs exclusive global supply pact with Galen for chemotherapy drug, DaunoXome (LON:CLIN)
pharmabiz.com - June 16 at 8:38 AM
4-traders.com logoClinigen : Clinigen and Galen enter exclusive Global Access agreement for chemotherapydrug DaunoXome® (LON:CLIN)
www.4-traders.com - June 14 at 4:10 PM
wsj.com logoClinigen Inks Global Access Pact for Chemotherapy Drug DaunoXome (LON:CLIN)
www.wsj.com - June 14 at 4:10 PM
proactiveinvestors.co.uk logoClinigen signs exclusive global access agreement for cancer treatment (LON:CLIN)
www.proactiveinvestors.co.uk - June 14 at 4:10 PM
wsj.com logo[$$] Clinigen Inks Global Access Pact for Chemotherapy Drug (LON:CLIN)
www.wsj.com - June 14 at 2:39 PM
publicnow.com logoClinigen Group - Clinigen and Galen enter exclusive Global Access agreement for chemotherapydrug DaunoXome® (LON:CLIN)
www.publicnow.com - June 14 at 4:19 AM

Social


Last Updated on 9/30/2016 by MarketBeat.com Staff